Mammary-derived Growth Inhibitor Tumor Suppressor Activity of the Gene Encoding

The gene encoding mammary-derived growth inhibitor (MOGI), a protein previously purified from bovine mammary gland and shown to have modest antiproliferative activity for human breast cancer cells in vitro, is demonstrated to function as a potent tumor suppressor gene. Human breast cancer cells transfected with a MDGI expression construct exhibited differentiated morphology, reduced proliferation rate, reduced clonogenicity in soft agar, and reduced tumorgenicity in nude mice rela tive to mock-transfected or untransfected controls. We mapped the hu man homologue of this gene to chromosome lp33-35, a locus previously shown to exhibit frequent loss of heterozygosity in human breast cancer. MDGI immunoreactivity was detected in epithelial cells of human breast tissue, but not on due-lai carcinoma cells on the same sections. Our results suggest that MDGI is a strong candidate for the distal Ip breast tumor suppressor gene. Furthermore, as prior reports have demonstrated that MDGI is hormonally regulated in breast epithelial cells and maximally expressed at the time of maximal differentiated function (just prior to lactation), MDGI is a candidate mediator of the differ entiating effect of pregnancy on breast epithelial cells, which may be involved in the protective effect of early parity on subsequent breast cancer incidence.